The Cost-Effectiveness of Silver-Impregnated Occlusive Dressings for Infection Prevention After Total Joint Arthroplasty

2020 ◽  
Author(s):  
Alexander J. Toppo ◽  
Nicholas R. Pagani ◽  
Michael A. Moverman ◽  
Richard N. Puzzitiello ◽  
Mariano E. Menendez ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Total Joint Arthroplasty ◽  
Infection Prevention ◽  
Joint Arthroplasty ◽  
Occlusive Dressings ◽  
The Cost

Response to Letter to the Editor on “The Cost-Effectiveness of Silver-Impregnated Occlusive Dressings for Infection Prevention After Total Joint Arthroplasty”

2021 ◽  
Vol 36 (5) ◽  
pp. e57
Author(s):  
Alexander J. Toppo ◽  
Nicholas R. Pagani ◽  
Michael A. Moverman ◽  
Richard N. Puzzitiello ◽  
Mariano E. Menendez ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Total Joint Arthroplasty ◽  
Infection Prevention ◽  
Joint Arthroplasty ◽  
Letter To The Editor ◽  
Occlusive Dressings ◽  
The Cost

The Cost-Effectiveness of Preoperative Staphylococcus aureus Screening and Decolonization in Total Joint Arthroplasty

2018 ◽  
Vol 33 (7) ◽  
pp. S191-S195 ◽  
Author(s):  
Yehuda E. Kerbel ◽  
Anisha R. Sunkerneni ◽  
Gregory J. Kirchner ◽  
John P. Prodromo ◽  
Vincent M. Moretti
Keyword(s):  
Staphylococcus Aureus ◽  
Cost Effectiveness ◽  
Total Joint Arthroplasty ◽  
Joint Arthroplasty ◽  
The Cost

The Cost Effectiveness of Dilute Betadine Lavage for Infection Prophylaxis in Total Joint Arthroplasty

2019 ◽  
Vol 34 (7) ◽  
pp. S307-S311 ◽  
Author(s):  
Yehuda E. Kerbel ◽  
Gregory J. Kirchner ◽  
Anisha R. Sunkerneni ◽  
Alexander M. Lieber ◽  
Vincent M. Moretti
Keyword(s):  
Cost Effectiveness ◽  
Total Joint Arthroplasty ◽  
Joint Arthroplasty ◽  
Infection Prophylaxis ◽  
The Cost

scholarly journals The cost-effectiveness of total joint arthroplasty: A systematic review of published literature

2012 ◽  
Vol 26 (5) ◽  
pp. 649-658 ◽  
Author(s):  
Meghan E. Daigle ◽  
Alexander M. Weinstein ◽  
Jeffrey N. Katz ◽  
Elena Losina
Keyword(s):  
Systematic Review ◽  
Cost Effectiveness ◽  
Total Joint Arthroplasty ◽  
Joint Arthroplasty ◽  
The Cost

The cost of infection after total joint arthroplasty

2012 ◽  
Vol 23 (6) ◽  
pp. 554-559 ◽  
Author(s):  
Andrew Mulder ◽  
Sami Jaafar ◽  
David C. Markel
Keyword(s):  
Total Joint Arthroplasty ◽  
Joint Arthroplasty ◽  
The Cost

Pharmacologic Hemostatic Agents in Total Joint Arthroplasty—A Cost-Effectiveness Analysis

2018 ◽  
Vol 33 (7) ◽  
pp. 2092-2099.e9 ◽  
Author(s):  
Dipak B. Ramkumar ◽  
Niveditta Ramkumar ◽  
Stephanie J. Tapp ◽  
Wayne E. Moschetti
Keyword(s):  
Cost Effectiveness ◽  
Total Joint Arthroplasty ◽  
Cost Effectiveness Analysis ◽  
Joint Arthroplasty ◽  
Hemostatic Agents ◽  
Effectiveness Analysis

The Cost of Poor Mental Health in Total Joint Arthroplasty

2020 ◽  
Vol 35 (12) ◽  
pp. 3432-3436 ◽  
Author(s):  
Amy Ahn ◽  
Daniel J. Snyder ◽  
Aakash Keswani ◽  
Christopher Mikhail ◽  
Jashvant Poeran ◽  
...  
Keyword(s):  
Mental Health ◽  
Total Joint Arthroplasty ◽  
Poor Mental Health ◽  
Joint Arthroplasty ◽  
The Cost

The Cost-Effectiveness of Closed Incisional Negative Pressure Wound Therapy for Infection Prevention after Revision Total Knee Arthroplasty

2021 ◽  
Author(s):  
Nicholas R. Pagani ◽  
Michael A. Moverman ◽  
Richard N. Puzzitiello ◽  
Mariano E. Menendez ◽  
Joseph J. Kavolus
Keyword(s):  
Cost Effectiveness ◽  
Infection Prevention ◽  
Negative Pressure Wound Therapy ◽  
Cost Effective ◽  
Revision Total Knee Arthroplasty ◽  
Infection Rates ◽  
Initial Infection ◽  
Total Knee ◽  
The Cost ◽  
Revision Tka

AbstractRecent investigations have shown that closed incisional negative pressure wound therapy (ciNPWT) decreases the rate of postoperative wound complications following revision total knee arthroplasty (TKA). In this study, we used a break-even analysis to determine whether ciNPWT is a cost-effective measure for reducing prosthetic joint infection (PJI) after revision TKA. The cost of ciNPWT, cost of treatment for PJI, and baseline infection rates following revision TKA were collected from institutional data and the literature. The absolute risk reduction (ARR) in infection rate necessary for cost-effectiveness was calculated using break-even analysis. Using our institutional cost of ciNPWT ($600), this intervention would be cost-effective if the initial infection rate of revision TKA (9.0%) has an ARR of 0.92%. The ARR needed for cost-effectiveness remained constant across a wide range of initial infection rates and declined as treatment costs increased. The use of ciNPWT for infection prevention following revision TKA is cost-effective at both high and low initial infection rates, across a broad range of treatment costs, and at inflated product expenses.

Sign in / Sign up

Export Citation Format

Share Document